Dictionary

allow_url_fopen is ENABLED Dictionary Search

xenon

Synonyms

Noun

1. Xe

2. atomic number 54, chemical element, element, noble gas, inert gas, argonon

Usage
2002-2006 CADILLAC ESCALADE COMPLETE LEFT SIDE HID XENON HEADLIGHT LIGHT OEM - alessandria24.com
Wedbush lowers Xenon Pharmaceuticals stock price target to $63 - Investing.com
Xenon Pharmaceuticals’ seizure drug shows strong efficacy in late-stage trial - statnews.com
Xenon phase 3 epilepsy readout 'blows away' expectations, stock soars - Fierce Biotech
XENE: Wedbush Adjusts Target Price for Xenon Pharmaceuticals | X - GuruFocus
HighVista Strategies LLC Increases Stock Holdings in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Xenon To Seek Approval of First-in-Class Epilepsy Drug After Exceeding Phase 3 Expectations - BioSpace
Analysts tout market potential of Xenon’s epilepsy drug on Phase III win - Clinical Trials Arena
Why This Biotech, Up 47%, Could Spark The Next Buyout Frenzy - Investor's Business Daily
Biopharma bites: Salspera's IPO plans, plus $600M+ raises for Xenon, Dianthus - FirstWord Pharma
Finance Watch: As IPO Market Quiets Again, Xenon, Dianthus Price Big Follow-Ons - Citeline News & Insights
Assessing Xenon Pharmaceuticals (XENE) Valuation After A Sharp Recent Share Price Surge - Yahoo Finance
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares - GlobeNewswire
Xenon Pharmaceuticals (XENE) sets June 2, 2026 annual shareholder meeting and April 7 record date - Stock Titan
Xenon Pharmaceuticals (XENE) Climbs 31.7% as Epilepsy Treatment Moves Forward - Insider Monkey
Xenon Pharmaceuticals Nets $707.7 Million in $57 Share Offering With Pre-Funded Warrants - TradingView
UCB says Bimzelx tops Skyrizi in trial; Xenon, Dianthus set share sales - Endpoints News
Xenon’s seizure drug study reads out soon. Here’s what to expect - statnews.com
Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS) - GlobeNewswire
Xenon gas does not help elite climbers - UW Homepage
Xenon Pharmaceuticals (XENE) CLO sells shares to cover PSU taxes - Stock Titan
Xenon Pharmaceuticals Inc. Prices Upsized Public Offering, Anticipated Gross Proceeds of Approximately $650 Million - Quiver Quantitative
Is Xenon Pharmaceuticals (XENE) Pricing Look Compelling After Recent 37% Weekly Share Surge? - simplywall.st
Xenon tees up FDA filing after seizure med delivers 'home run' in Phase III - FirstWord Pharma
Xenon Pharmaceuticals Announces Pricing Of Upsized $650.0 Million Public Offering - TradingView
Xenon Sets Date for 2026 Annual Shareholder Meeting - TipRanks
BofA raises Xenon Pharmaceuticals price target on trial success - Investing.com
Xenon gets Phase 3 win with epilepsy drug, fueling blockbuster hopes for its first launch - Endpoints News
[144] Xenon Pharmaceuticals Inc. SEC Filing - Stock Titan
Why Xenon Pharmaceuticals (XENE) Is Up 38.4% After Strong Phase 3 Azetukalner Seizure Data And FDA Plans - simplywall.st
Xenon: Shares Soar On Seizure Data, But Valuation May Be Overcooked (NASDAQ:XENE) - Seeking Alpha
The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE) - The Chronicle-Journal
Xenon hits a ‘home run’ in epilepsy; FDA restarts review of Duchenne cell therapy - Yahoo Finance
Xenon’s X-TOLE2 Trial Completion Puts XEN1101 in Focus for Epilepsy Investors - TipRanks
Xenon Q4 Loss Wider Than Expected, Pipeline Development in Focus - Yahoo Finance
Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update - Yahoo Finance
Xenon awaiting critical epilepsy drug study results that could lead to FDA approval - The Globe and Mail
$500M stock sale: neuroscience drug maker Xenon tests market appetite - Stock Titan
Xenon Pharmaceuticals Clears Key Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily
Size-inverse molecular sieving xenon/krypton separation through cation-tuned gating effect within Linde Type A zeolites - Nature
Xenon to Announce Topline Results from Phase 3 X-TOLE2 - GlobeNewswire
Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference - Yahoo Finance
Polarean Expands Xenon MRI Platform into Cardiopulmonary Drug Development - Diagnostic and Interventional Cardiology | DAIC
Xenon Raises $650 Million in Upsized U.S. Equity Offering - TipRanks
Eles Semiconductor Equipment Says Xenon Crosses 30% Threshold, Owns 42.405% - TradingView
Xenon Pharmaceuticals to Announce Topline Data from Phase 3 X-TOLE2 Study of Azetukalner for Focal Onset Seizures - Quiver Quantitative
Can Xenon Help You Climb Everest Faster? These Scientists Aren't Buying the Hype. - Outside Magazine
Xenon Pharmaceuticals stock surges 40% on positive trial data - Investing.com
Xenon stock soars as B.C. drug developer reports strong results for epilepsy treatment - The Globe and Mail
A Look At Xenon Pharmaceuticals (XENE) Valuation After Wolfe Research’s New Favorable Coverage - Yahoo Finance
Xenon Q4 Loss Wider Than Expected, Pipeline Development in Focus - Zacks Investment Research
Xenon’s Seizure Drug Data Make A Strong Case For Clinical Use - Citeline News & Insights
Krypton/Xenon separation at room temperature in a flexible coordinative framework sorbent - Nature
Xenon Pharmaceuticals Stock Scores RS Rating Upgrade - Investor's Business Daily
A Look At Xenon Pharmaceuticals (XENE) Valuation After Recent Share Price Drift Without Clear Catalyst - simplywall.st
XENE: Wedbush Raises Price Target for Xenon Pharmaceuticals | XE - GuruFocus
Is Xenon Pharmaceuticals (XENE) Quietly Reframing Its Epilepsy Bet Through Equity Awards and New Data? - Yahoo Finance
Stocks making the biggest moves midday: Chevron, Hims and Hers, Xenon Pharma, Vertiv and more - CNBC
Phase 3 success for Xenon (NASDAQ: XENE) epilepsy candidate azetukalner - Stock Titan
XENE: HC Wainwright Raises Price Target for Xenon Pharmaceuticals | XENE Stock News - GuruFocus
Xenon Pharmaceuticals (XENE) widens 2025 loss while cash runway reaches into 2027 - Stock Titan
Is Xenon Pharmaceuticals (XENE) Offering An Opportunity After Recent Share Price Volatility? - simplywall.st
Rab Xenon Synthetic Jacket Review - Switchback Travel
Xenon Pharmaceuticals Announces Proposed Public Offering - Bitget
Xenon Pharmaceuticals Rallies After Pivotal Data Shows Major Drop In Monthly Seizures - Benzinga
XENE Surges Over 40% as Xenon Pharmaceuticals Stock Climbs - GuruFocus
Xenon Pharmaceuticals: Derisked Pipeline Ahead Of Critical 2026 Phase 3 Readout (NASDAQ:XENE) - Seeking Alpha
The Potassium Channel Breakthrough: A Deep-Dive on Xenon Pharmaceuticals (XENE) - The Chronicle-Journal
Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025 - GlobeNewswire
Crude Oil Rises Around 4%; Xenon Pharmaceuticals Shares Surge - Benzinga
Xenon Pharmaceuticals Stock Jumps as Analysts Raise Price Targets - StocksToTrade
Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data - The Motley Fool
Xenon Pharmaceuticals Awaits Key Study Results Amid Analyst Upgrades - StocksToTrade
Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
50% and 61% Gains in a Single Day: Why XENE and RLMD Soared Today - 24/7 Wall St.
Xenon Pharmaceuticals Reports Significant Long-Term Efficacy of Azetukalner in Epilepsy at AES 2025 - Quiver Quantitative
Xenon Pharmaceuticals: Buy Rating Backed by Superior X-TOLE2 Phase 3 Results and Commercial Upside for Azetukalner in Focal Epilepsy - TipRanks
Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Neuronal ‘off switch’ gets closer to reality - Nature
Xenon earnings loom as investors brace for Phase 3 catalyst By Investing.com - Investing.com
Xenon Pharmaceuticals (XENE): Losses Widen 37% Annually, Challenging Bullish Revenue Growth Expectations - Yahoo Finance
When climbing Mount Everest, is it cheating to use xenon gas? - National Geographic
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
HydroX, a light dark matter search with hydrogen-doped liquid xenon time projection chambers - Nature
Cantor Fitzgerald raises Xenon Pharmaceuticals stock price target to $55 - Investing.com
Xenon Pharmaceuticals Inc. to Present at 44th Annual J.P. Morgan Healthcare Conference in January 2026 - Quiver Quantitative
RBC Capital Maintains Xenon Pharmaceuticals (XENE) Outperform Recommendation - Nasdaq
Did Higher-Than-Expected Losses Just Shift Xenon Pharmaceuticals' (XENE) Investment Narrative? - Yahoo Finance
Silver-infused zeolite efficiently separates xenon from krypton for industrial use - Phys.org
Ashlar-Vellum Launches Xenon CAD on the Apple Mac App Store - PRWeb
Xenon Pharmaceuticals Witnesses Market Momentum Following Strategic Developments - timothysykes.com
Commodore Announces Xenon 3: Hyperblast For Steam, Switch And PlayStation - Time Extension
Xenon Pharmaceuticals registers $400M of common shares for ATM offering - TradingView
Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus - Zacks Investment Research
Xenon Pharmaceuticals Refreshes $400 Million ATM Equity Program - TipRanks
Xenon Announces Investor Webinar Highlighting Azetukalner and Epilepsy Data from AES 2025 - Yahoo Finance
Ten new Xenon hires receive 42,300 stock options vesting over 4 years - Stock Titan
Xenon Pharmaceuticals: Pushing Azetukalner Towards Finish Line With Phase 3 2026 Data Release - Seeking Alpha
Stocks With Rising Relative Strength: Xenon Pharmaceuticals - Investor's Business Daily
Xenon Highlights 2025 Results and Expands Late-Stage Pipeline - TipRanks
Foreign Language Equivalents
Foreign Language Equivalents of 'xenon'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
xebon,   xennon,   xeonn,   xneon,   xenpn,   xenom,   xnon,   xeenon,   cenon,   xrnon,   xenin,   exnon,   zenon,   xeon,   xeno,   xenoon,   xwnon,   xenonn,   xenob,   xemon,   xenno,   enon,   xxenon,   xenn
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z